Harvard Bioscience (HBIO) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $6.08 -8.43%
Financial Fact:
Research and development expenses: 1.31M
Today's EPS Names:
PLCE, COE, JVA, More
Financial Fact:
Research and development expenses: 1.31M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q1 EPS of ($0.01), in-line with the analyst estimate of ($0.01). Revenue for the quarter came in at $21.77 million versus the consensus estimate of $20 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Frequency Electronics secures $10 million credit facility with JPMorgan
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
